机译:三阴性和基础型乳腺癌的脑转移破坏血脑屏障,但HER2 / neu阳性乳腺癌没有
Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan;
Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan;
|Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan;
Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan;
Department of Management Science, Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan;
Department of Surgical Pathology, Sapporo Medical School of Medicine, Sapporo, Japan;
Dako Japan, Inc., Tokyo, Japan;
Neurosurgery Division, National Cancer Center Hospital, Tokyo, Japan;
Neurosurgery Division, National Cancer Center Hospital, Tokyo, Japan;
Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan|Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan;
blood brain barrier; brain metastasis; glucose transporter 1; breast cancer resistance protein; and breast cancer;
机译:三阴性和基础型乳腺癌的脑转移破坏了血脑屏障,而HER2 / neu阳性乳腺癌则没有。
机译:三重阴性和基础型乳腺癌脑转移的血脑屏障的破坏,但不是Her2 / Neu阳性乳腺癌。
机译:三重阴性和基础型乳腺癌脑转移的血脑屏障的破坏,但不是Her2 / Neu阳性乳腺癌。
机译:超声聚焦诱导的血脑/血肿瘤屏障破坏后脑肿瘤中抗癌剂转运的评估
机译:诱导神经干细胞疗法治疗三阴性乳腺癌和脑转移
机译:通过血脑屏障进入脑癌和实验性脑转移的新型紫杉醇衍生物的Ang1005的摄取
机译:三重阴性和基础乳腺癌脑转移的血脑屏障的破坏,但Nother2 / Neu阳性乳腺癌
机译:乳腺癌脑转移的发病机制与血脑屏障异质性